As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...

In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Advanced computing is being utilized to predict a key occurrence in nuclear fission reactions, which could help improve energy production in future plants, according to a new stud ...

With rising temperatures intensifying precipitation and flood risks, water authorities are rethinking dam safety and ...

People who lose their visual imagination after a stroke share damage to a single neural circuit. A new analysis maps these ...

Although Duolingo suffered a severe drop following its Q4 earnings disclosure, the smart money seems intrigued by DUOL stock ...

Canada: Researchers have found in a new randomized clinical trial that a 4-week vancomycin pulse and taper regimen showed a ...